公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: A case-control study | Johnson N.; Dudbridge F.; Orr N.; Gibson L.; Jones M.E.; Schoemaker M.J.; Folkerd E.J.; Haynes B.P.; Hopper J.L.; Southey M.C.; Dite G.S.; Apicella C.; Schmidt M.K.; Broeks A.; Van't Veer L.J.; Atsma F.; Muir K.; Lophatananon A.; Fasching P.A.; Beckmann M.W.; Ekici A.B.; Renner S.P.; Sawyer E.; Tomlinson I.; Kerin M.; Miller N.; Burwinkel B.; Marme F.; Schneeweiss A.; Sohn C.; Gu?nel P.; Truong T.; Cordina E.; Menegaux F.; Bojesen S.E.; Nordestgaard B.G.; Flyger H.; Milne R.; Zamora M.P.; Perez J.I.A.; Benitez J.; Bernstein L.; Anton-Culver H.; Ziogas A.; Dur C.C.; Brenner H.; M?ller H.; Arndt V.; Dieffenbach A.K.; Meindl A.; Heil J.; Bartram C.R.; Schmutzler R.K.; Brauch H.; Justenhoven C.; Ko Y.-D.; Nevanlinna H.; Muranen T.A.; Aittom?ki K.; Blomqvist C.; Matsuo K.; D?rk T.; Bogdanova N.V.; Antonenkova N.N.; Lindblom A.; Mannermaa A.; Kataja V.; Kosma V.-M.; Hartikainen J.M.; Chenevix-Trench G.; Beesley J.; Wu A.H.; Van den Berg D.; Tseng C.-C.; Lambrechts D.; Smeets D.; Neven P.; Wildiers H.; Chang-Claude J.; Rudolph A.; Nickels S.; Flesch-Janys D.; Radice P.; Peterlongo P.; Bonanni B.; Pensotti V.; Couch F.J.; Olson J.E.; Wang X.; Fredericksen Z.; Pankratz V.S.; Giles G.G.; Severi G.; Baglietto L.; Haiman C.; Simard J.; Goldberg M.S.; Labr?che F.; Dumont M.; Soucy P.; Teo S.; Yip C.H.; Phuah S.Y.; Cornes B.K.; Kristensen V.N.; Aln?s G.G.; B?rresen-Dale A.-L.; Zheng W.; Winqvist R.; Pylk?s K.; Jukkola-Vuorinen A.; Grip M.; Andrulis I.L.; Knight J.A.; Glendon G.; Mulligan A.M.; Devillee P.; Figueroa J.; Chanock S.J.; Lissowska J.; Sherman M.E.; Hall P.; Schoof N.; Hooning M.; Hollestelle A.; Oldenburg R.A.; Tilanus-Linthorst M.; Liu J.; Cox A.; Brock I.W.; Reed M.W.; Cross S.S.; Blot W.; Signorello L.B.; Pharoah P.D.; Dunning A.M.; Shah M.; Kang D.; Noh D.-Y.; Park S.K.; Choi J.-Y.; Hartman M.; Miao H.; Lim W.Y.; Tang A.; Hamann U.; F?rsti A.; R?diger T.; Ulmer H.U.; Jakubowska A.; Lubinski J.; Jaworska-Bieniek K.; Durda K.; Sangrajrang S.; Gaborieau V.; Brennan P.; McKay J.; Slager S.; Toland A.E.; Vachon C.; Yannoukakos D.; Shen C.-Y.; Yu J.-C.; CHIUN-SHENG HUANG ; Hou M.-F.; Gonz?lez-Neira A.; Tessier D.C.; Vincent D.; Bacot F.; Luccarini C.; Dennis J.; Michailidou K.; Bolla M.K.; Wang J.; Easton D.F.; Garc?a-Closas M.; Dowsett M.; Ashworth A.; Swerdlow A.J.; Peto J.; Silva I.S.; Fletcher O.; The GENICA (Gene Environment Interaction; Breast Cancer in Germany) Network, kConFab Investigators, Australian Ovarian Cancer Study Group | Breast Cancer Research | 13 | 13 | |
2020 | Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study | CHIUN-SHENG HUANG ; Yu A.L.; Tseng L.-M.; Chow L.W.C.; Hou M.-F.; Hurvitz S.A.; Schwab R.B.; L Murray J.; Chang H.-K.; Chang H.-T.; Chen S.-C.; Kim S.-B.; Hung J.-T.; Ueng S.-H.; Lee S.-H.; Chen C.-C.; Rugo H.S. | Journal for immunotherapy of cancer | 30 | 27 | |
2010 | Identification of a functional genetic variant at 16q12.1 for breast cancer risk: Results from the Asia breast cancer consortium | Long J.; Cai Q.; Shu X.-O.; Qu S.; Li C.; Zheng Y.; Gu K.; Wang W.; Xiang Y.-B.; Cheng J.; Chen K.; Zhang L.; Zheng H.; Shen C.-Y.; CHIUN-SHENG HUANG ; Hou M.-F.; Shen H.; Hu Z.; Wang F.; Deming S.L.; Kelley M.C.; Shrubsole M.J.; Khoo U.S.; Chan K.Y.K.; Chan S.Y.; Haiman C.A.; Henderson B.E.; le Marchand L.; Iwasaki M.; Kasuga Y.; Tsugane S.; Matsuo K.; Tajima K.; Iwata H.; Huang B.; Shi J.; Li G.; Wen W.; Gao Y.-T.; Lu W.; Zheng W. | PLoS Genetics | 102 | 92 | |
2006 | Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: Analysis of 10-year longitudinal cohort in Taiwan | WEN-HUNG KUO ; Yen A.M.-F.; PO-HUANG LEE ; Hou M.-F.; Chen S.-C.; Chen K.-M.; Chen, Tony Hsiu Hsi ; KING-JEN CHANG | Breast Cancer Research and Treatment | 26 | 28 | |
2012 | International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases | Chow E.; Nguyen J.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Bottomley A. | Cancer | 66 | 55 | |
2012 | An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases | Zeng L.; Chow E.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Bedard G.; Bottomley A. | Supportive Care in Cancer | 28 | 19 | |
2011 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: Findings from the Breast Cancer Association Consortium | Broeks A.; Schmidt M.K.; Sherman M.E.; Couch F.J.; Hopper J.L.; Dite G.S.; Apicella C.; Smith L.D.; Hammet F.; Southey M.C.; Van't Veer L.J.; De Groot R.; Smit V.T.H.B.M.; Fasching P.A.; Beckmann M.W.; Jud S.; Ekici A.B.; Hartmann A.; Hein A.; Schulz-Wendtland R.; Burwinkel B.; Marme F.; Schneeweiss A.; Sinn H.-P.; Sohn C.; Tchatchou S.; Bojesen S.E.; Nordestgaard B.G.; Flyger H.; ?rsted D.D.; Kaur-Knudsen D.; Milne R.L.; P?rez J.I.A.; Zamora P.; Rodr?guez P.M.; Ben?tez J.; Brauch H.; Justenhoven C.; Ko Y.-D.; Network T.G.; Hamann U.; Fischer H.-P.; Br?ning T.; Pesch B.; Chang-Claude J.; Wang-Gohrke S.; Bremer M.; Karstens J.H.; Hillemanns P.; D?rk T.; Nevanlinna H.A.; Heikkinen T.; Heikkil? P.; Blomqvist C.; Aittom?ki K.; Aaltonen K.; Lindblom A.; Margolin S.; Mannermaa A.; Kosma V.-M.; Kauppinen J.M.; Kataja V.; Auvinen P.; Eskelinen M.; Soini Y.; Chenevix-Trench G.; Spurdle A.B.; Beesley J.; Chen X.; Holland H.; Lambrechts D.; Claes B.; Vandorpe T.; Neven P.; Wildiers H.; Flesch-Janys D.; Hein R.; L?ning T.; Kosel M.; Fredericksen Z.S.; Wang X.; Giles G.G.; Baglietto L.; Severi G.; McLean C.; Haiman C.A.; Henderson B.E.; Le Marchand L.; Kolonel L.N.; Aln?s G.G.; Kristensen V.; B?rresen-Dale A.-L.; Hunter D.J.; Hankinson S.E.; Andrulis I.L.; Mulligan A.M.; O'Malley F.P.; Devilee P.; Huijts P.E.A.; Tollenaar R.A.E.M.; Van Asperen C.J.; Seynaeve C.S.; Chanock S.J.; Lissowska J.; Brinton L.; Peplonska B.; Figueroa J.; Yang X.R.; Hooning M.J.; Hollestelle A.; Oldenburg R.A.; Jager A.; Kriege M.; Ozturk B.; Van Leenders G.J.L.H.; Hall P.; Czene K.; Humphreys K.; Liu J.; Cox A.; Connley D.; Cramp H.E.; Cross S.S.; Balasubramanian S.P.; Reed M.W.R.; Dunning A.M.; Easton D.F.; Humphreys M.K.; Caldas C.; Blows F.; Driver K.; Provenzano E.; Lubinski J.; Jakubowska A.; Huzarski T.; Byrski T.; Cybulski C.; Gorski B.; Gronwald J.; Brennan P.; Sangrajrang S.; Gaborieau V.; Shen C.-Y.; Hsiung C.-N.; Yu J.-C.; Chen S.-T.; Hsu G.-C.; Hou M.-F.; CHIUN-SHENG HUANG ; Anton-Culver H.; Ziogas A.; Pharoah P.D.P.; Garcia-Closas M.; kConFab51, AOCS50,51 | Human Molecular Genetics | 148 | 139 | |
2014 | MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis | Chan S.-H.; Huang W.-C.; Chang J.-W.; KING-JEN CHANG ; WEN-HUNG KUO ; Wang M.-Y.; Lin K.-Y.; Uen Y.-H.; Hou M.-F.; Lin C.-M.; Jang T.-H.; Tu C.-W.; Lee Y.-R.; Lee Y.-H.; Tien M.-T.; Wang L.-H. | Oncogene | 120 | 113 | |
2020 | Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with ? 2 HER2-directed regimens: Phase III NALA trial | Saura C.; Oliveira M.; Feng Y.-H.; Dai M.-S.; Chen S.-W.; Hurvitz S.A.; Kim S.-B.; Moy B.; Delaloge S.; Gradishar W.; Masuda N.; Palacova M.; Trudeau M.E.; Mattson J.; Yap Y.S.; Hou M.-F.; De Laurentiis M.; Yeh Y.-M.; Chang H.-T.; Yau T.; Wildiers H.; Haley B.; Fagnani D.; YEN-SHEN LU ; Crown J.; Lin J.; Takahashi M.; Takano T.; Yamaguchi M.; Fujii T.; Yao B.; Bebchuk J.; Keyvanjah K.; Bryce R.; Brufsky A.; NALA Investigators | Journal of Clinical Oncology | 360 | 311 | |
2016 | Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer | Lu Y.-C.; Ou-Yang F.U.; Hsieh C.-M.; KING-JEN CHANG ; Chen D.-R.; Tu C.-W.; Wang H.-C.; Hou M.-F. | In vivo (Athens, Greece) | 7 | 0 | |
2014 | Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30 | Cramarossa G.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Sahgal A.; Lam H.; Pulenzas N.; Chow E. | Expert Review of Pharmacoeconomics and Outcomes Research | 7 | 7 | |
2013 | Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30 | Lam K.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Pharmd F.F.; WEI-CHU CHIE ; Sahgal A.; Poon M.; Chow E. | Journal of Palliative Medicine | 11 | 10 | |
2012 | Quality of life after palliative radiation therapy for patients with painful bone metastases: Results of an international study validating the EORTC QLQ-BM22 | Zeng L.; Chow E.; Bedard G.; Zhang L.; Fairchild A.; Vassiliou V.; Alm El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Bottomley A. | International Journal of Radiation Oncology Biology Physics | 80 | 68 | |
2013 | Quality of life assessment in Taiwanese patients with bone metastases from breast cancer receiving zoledronic acid | Chao T.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Yeh D.-C.; Wang H.-C.; Huang W.-T.; Rau K.-M.; KING-JEN CHANG ; Yang T.-L.; Lee K.-D.; Tai C.-J.; Tseng L.-M.; Hou M.-F. | Anticancer Research | 1 | ||
2016 | Symptom clusters analysis in bone metastases patients | Chiu L.; Chow E.; Chiu N.; Zhang L.; Bedard G.; Fairchild A.; Vassiliou V.; El-Din M.A.A.; Jesus-Garcia R.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Satoh T.; Ma B.B.; Lam H.; Bottomley A. | Cancer: Pain and Symptom Management | 0 | ||
2013 | Symptom clusters analysis in bone metastases patients using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Bone Metastases Module (EORTC QLQ-BM22) | Chiu L.; Chow E.; Chiu N.; Zhang L.; Bedard G.; Fairchild A.; Vassiliou V.; El-Din M.A.A.; Jesus-Garcia R.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Satoh T.; Ma B.B.Y.; Lam H.; Bottomley A. | Journal of Pain Management | 0 | ||
2018 | Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7–CYFIP1-mediated signaling pathway | Chang J.-W.; WEN-HUNG KUO ; Lin C.-M.; Chen W.-L.; Chan S.-H.; Chiu M.-F.; Chang I.-S.; Jiang S.-S.; Tsai F.-Y.; Chen C.-H.; PEI-HSIN HUANG ; KING-JEN CHANG ; Lin K.-T.; Lin S.-C.; Wang M.-Y.; Uen Y.-H.; Tu C.-W.; Hou M.-F.; Tsai S.-F.; Shen C.-Y.; Tung S.-L.; Wang L.-H. | Oncogene | 33 | 32 |